Reporting of Incidence and Outcome of Bone Metastases in Clinical Trials Enrolling Patients with Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma—A Systematic Review by Anita Brouns, Safiye Dursun, Gerben Bootsma, Anne-Marie C. Dingemans, Lizza Hendriks

Get full text

Non-Radiation Based Early Pain Relief Treatment Options for Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: A Systematic Review by Anita J. W. M. Brouns, Anita J. W. M. Brouns, Ben H. De Bie, Marieke H. J. van den Beuken-van Everdingen, Anne-Marie C. Dingemans, Anne-Marie C. Dingemans, Lizza E. L. Hendriks

Get full text

MicroRNA expression and clinical outcome of small cell lung cancer. by Jih-Hsiang Lee, Johannes Voortman, Anne-Marie C Dingemans, Donna M Voeller, Trung Pham, Yisong Wang, Giuseppe Giaccone

Get full text

Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 Trial by Anita J. W. M. Brouns, Anita J. W. M. Brouns, Lizza E. L. Hendriks, Vincent van der Noort, Ben E. E. M van de Borne, Franz M. N. H. Schramel, Harry J. M. Groen, Bonne Biesma, Hans J. M. Smit, Anne-Marie C. Dingemans, Anne-Marie C. Dingemans

Get full text

Association of RANKL and EGFR gene expression with bone metastases in patients with metastatic non-small cell lung cancer by Anita J.W.M. Brouns, Anita J.W.M. Brouns, Anita J.W.M. Brouns, Lizza E.L. Hendriks, Lizza E.L. Hendriks, Iris J. Robbesom-van den Berge, Annemariek J.H.M. Driessen, Guido M.J.M. Roemen, Britt L.J. van Herpen, Zoë Dekkers, Bas Heitzer, Daphne J.G. Leunissen, Laura Moonen, Ragnar Lunde, Marcel Westenend, Marjolein van Driel, Ernst-Jan M. Speel, Anne-Marie C. Dingemans, Anne-Marie C. Dingemans, Anne-Marie C. Dingemans

Get full text

Galectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer. by Iris A Schulkens, Roy Heusschen, Vivian van den Boogaart, Robert-Jan van Suylen, Anne-Marie C Dingemans, Arjan W Griffioen, Victor L Thijssen

Get full text

Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology by Iris G. van der Sar, Marlies S. Wijsenbeek, Gert-Jan Braunstahl, Jason O. Loekabino, Anne-Marie C. Dingemans, Johannes C. C. M. In ‘t Veen, Catharina C. Moor

Get full text

The Authors reply: Comment on: “Handgrip weakness, low fat‐free mass, and overall survival in non‐small cell lung cancer treated with curative‐intent radiotherapy” by Burtin et al.... by Chris Burtin, Jacques Bezuidenhout, Karin J.C. Sanders, Anne‐Marie C. Dingemans, Annemie M.W.J. Schols, Stephanie T.H. Peeters, Martijn A. Spruit, Dirk K.M. De Ruysscher

Get full text

The prognostic value of weight and body composition changes in patients with non‐small‐cell lung cancer treated with nivolumab by Juliette H.R.J. Degens, Anne‐Marie C. Dingemans, Anna C.H. Willemsen, Hester A. Gietema, Daan P. Hurkmans, Joachim G. Aerts, Lizza E.L. Hendriks, Annemie M.W.J. Schols

Get full text

Screening for Brain Metastases in Patients With NSCLC: A Qualitative Study on the Psychologic Impact of Being Diagnosed With Asymptomatic Brain Metastases by Janna J.A. O. Schoenmaekers, MD, Jeroen Bruinsma, PhD, Claire Wolfs, PhD, Lidia Barberio, MSc, Anita Brouns, MD, Anne-Marie C. Dingemans, MD, PhD, Lizza E.L. Hendriks, MD, PhD

Get full text

Improving the tolerability of osimertinib by identifying its toxic limit by Bram C. Agema, G. D. Marijn Veerman, Christi M. J. Steendam, Daan A. C. Lanser, Tim Preijers, Cor van der Leest, Birgit C. P. Koch, Anne-Marie C. Dingemans, Ron H. J. Mathijssen, Stijn L. W. Koolen

Get full text

The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation by Willem J. A. Witlox, Bram L. T. Ramaekers, Jaap D. Zindler, Daniëlle B. P. Eekers, Judith G. M. van Loon, Lizza E. L. Hendriks, Anne-Marie C. Dingemans, Dirk K. M. De Ruysscher, Dirk K. M. De Ruysscher

Get full text

Quantitative modeling of tumor dynamics and development of drug resistance in non‐small cell lung cancer patients treated with erlotinib by Anyue Yin, G. D. Marijn Veerman, Johan G. C. vanHasselt, Christi M. J. Steendam, Hendrikus Jan Dubbink, Henk‐Jan Guchelaar, Lena E. Friberg, Anne‐Marie C. Dingemans, Ron H. J. Mathijssen, Dirk Jan A. R. Moes

Get full text

Influence of esomeprazole on the bioavailability of afatinib: A pharmacokinetic cross-over study in patients with non-small cell lung cancer by G.D. Marijn Veerman, Daan P. Hurkmans, Marthe S. Paats, Esther Oomen-de Hoop, Cor H. van der Leest, Eric R.E. van Thiel, Joachim G.J.V. Aerts, Roelof W. van Leeuwen, Anne-Marie C. Dingemans, Ron H.J. Mathijssen

Get full text

Characteristics of patients with advanced cancer preferring not to know prognosis: a multicenter survey study by Naomi C. A. van der Velden, Hanneke W. M. van Laarhoven, Sjaak A. Burgers, Lizza E. L. Hendriks, Filip Y. F. L. de Vos, Anne-Marie C. Dingemans, Joost Jansen, Jan-Maarten W. van Haarst, Joyce Dits, Ellen MA Smets, Inge Henselmans

Get full text

Invasive Aspergillosis Mimicking Metastatic Lung Cancer by Michiel J. E. G. W. Vanfleteren, Michiel J. E. G. W. Vanfleteren, Michiel J. E. G. W. Vanfleteren, Anne-Marie C. Dingemans, Veerle F. Surmont, Karim Y. Vermaelen, Alida A. Postma, Astrid M. L. Oude Lashof, Cordula C. M. Pitz, Lizza E. L. Hendriks

Get full text

Incidence of Bone Metastases and Skeletal-Related Events in Patients With EGFR-Mutated NSCLC Treated With Osimertinib by Anita J.W. M. Brouns, MD, Ard van Veelen, MSc, G. D. Marijn Veerman, MD, Christi Steendam, MD, Safiye Dursun, MD, Cor van der Leest, PhD, Sander Croes, PhD, Anne-Marie C. Dingemans, MD, PhD, Lizza E.L. Hendriks, PhD

Get full text

Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology by Fernando Gamarra, Julie-Lyn Noël, Alessandro Brunelli, Anne-Marie C. Dingemans, Enriqueta Felip, Mina Gaga, Bogdan Dragos Grigoriu, Georgia Hardavella, Rudolf M. Huber, Samuel Janes, Gilbert Massard, Paul Martin Putora, Jean-Paul Sculier, Philipp A. Schnabel, Sara Ramella, Dirk Van Raemdonck, Anne-Pascale Meert

Get full text

The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembr... by Edoardo Lenci, Luca Cantini, Federica Pecci, Valeria Cognigni, Veronica Agostinelli, Giulia Mentrasti, Alessio Lupi, Nicoletta Ranallo, Francesco Paoloni, Silvia Rinaldi, Linda Nicolardi, Andrea Caglio, Sophie Aerts, Alessio Cortellini, Corrado Ficorella, Rita Chiari, Massimo Di Maio, Anne-Marie C. Dingemans, Joachim G. J. V. Aerts, Rossana Berardi

Get full text

Hepatotoxicity in patients with non-small cell lung cancer treated with sotorasib after prior immunotherapy: a comprehensive clinical and pharmacokinetic analysisResearch in contex... by Sophie M. Ernst, Maaike M. Hofman, Tessa E. van der Horst, Marthe S. Paats, Frank W.J. Heijboer, Joachim G.J.V. Aerts, Daphne W. Dumoulin, Robin Cornelissen, Jan H. von der Thüsen, Peter de Bruijn, Esther Oomen-de Hoop, Ron H.J. Mathijssen, Stijn L.W. Koolen, Anne-Marie C. Dingemans

Get full text